1H-Thieno[3,4-d]imidazole-4-pentanamide, N-[2-(acetylamino)ethyl]hexahydro-2-oxo-, [3aS-(3aI+/-,4I(2),6aI+/-)]- | 111790-38-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 生物素及其衍生物
• 英文名称: 1H-Thieno[3,4-d]imidazole-4-pentanamide, N-[2-(acetylamino)ethyl]hexahydro-2-oxo-, [3aS-(3aI+/-,4I(2),6aI+/-)]-
• 英文别名: 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-(2-acetamidoethyl)pentanamide
• CAS: 111790-38-6
• 化学式: C₁₄H₂₄N₄O₃S
• 分子量: 328.43
• InChiKey: GQBWMEZVHFZRLQ-GVXVVHGQSA-N

文献信息

• Compounds and therapeutic uses thereof
  申请人：Centauri Therapeutics Limited (GB/GB)

  公开号：US10953100B2

  公开（公告）日：2021-03-23

  The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.

  本发明涉及具有将免疫反应与确定的治疗靶点联系起来的能力的新型化合物，涉及使用上述化合物治疗癌症和由感染性病原体介导和/或引起的疾病或紊乱，涉及含有上述化合物的组合物、制备上述化合物的工艺以及用于上述工艺的新型中间体。
• COMPOUNDS AND THERAPEUTIC USES THEREOF
  申请人：CENTAURI THERAPEUTICS LIMITED

  公开号：US20210369850A1

  公开（公告）日：2021-12-02

  The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.